- Home
- AMLX vs RXO Comparison
AMLX vs RXO Comparison
Compare AMLX & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMLX | RXO |
|---|---|---|
| Founded | 2014 | 2022 |
| Country | United States | United States |
| Employees | 136 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.0B |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | AMLX | RXO |
|---|---|---|
| Price | $27.68 | $27.79 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 18 |
| Target Price | ★ $42.64 | $27.96 |
| AVG Volume (30 Days) | 1.3M | ★ 3.7M |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 65.46 | ★ 72.81 |
| EPS | N/A | ★ N/A |
| Revenue | $380,786,000.00 | ★ $5,742,000,000.00 |
| Revenue This Year | N/A | $21.35 |
| Revenue Next Year | N/A | $10.54 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1612.94 | 26.20 |
| 52 Week Low | $10.83 | $10.43 |
| 52 Week High | $41.14 | $29.90 |
Technical Indicators
Market Signals| Indicator | AMLX | RXO |
|---|---|---|
| Relative Strength Index (RSI) | 54.29 | 62.79 |
| Support Level | $26.16 | $28.14 |
| Resistance Level | $34.35 | $29.05 |
| Average True Range (ATR) | 1.48 | 0.58 |
| MACD | 0.28 | -0.33 |
| Stochastic Oscillator | 70.80 | 54.14 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
About RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.